Satish Udare News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Intas launches DCGI-approved Tofacitinib Topical (JAKi) in Auto-Immune Condition Atopic Dermatitis (AD) for Indian patients

Intas launches DCGI-approved Tofacitinib Topical (JAKi) in Auto-Immune Condition Atopic Dermatitis (AD) for Indian patients
newkerala.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newkerala.com Daily Mail and Mail on Sunday newspapers.

Satish udareKabir sardanaCommunication services ltdIntas pharmaceuticals ltdTofacitinib topicalAuto immune condition atopic dermatitisTofacitinib ointmentAtopic dermatitisTopical calcineurin inhibitorsSenior consultant dermatologistAlok chaturvediAssociate executive vice presidentHead medical affairsActive pharmaceutical ingredientsBhattdirectorone advertisingCommunication services ltd mobile

Intas launches DCGI-approved Tofacitinib Topical JAKi in Auto-Immune Condition Atopic Dermatitis AD for Indian patients

(This story has not been edited by THE WEEK and is auto-generated from a PTI

Vibhuti bhattKabir sardanaSatish udareAdvertising communication services ltdIntas pharmaceuticalsIntas pharmaceuticals ltdPrnewswire intas pharmaceuticals ltdPharmaceuticals ltdTofacitinib ointmentAtopic dermatitisTopical calcineurin inhibitorsSenior consultant dermatologistAlok chaturvediAssociate executive vice presidentHead medical affairsActive pharmaceutical ingredients

Intas launches Tofacitinib Ointment for Atopic Dermatitis patients

Intas launches Tofacitinib Ointment for Atopic Dermatitis patients
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Alok chaturvediKabir sardanaSatish udareIntas pharmaceuticalsIntas pharmaceuticals ltd onIntas pharmaceuticals ltdAtopic dermatitisController generalAssociate executive vice presidentHead medical affairsTofacitinib ointmentImport alertSenior consultant dermatologistTopical calcineurin inhibitors

Intas launches DCGI-approved Tofacitinib Topical (JAKi) in Auto-Immune Condition Atopic Dermatitis (AD) for Indian patients

Intas launches DCGI-approved Tofacitinib Topical (JAKi) in Auto-Immune Condition Atopic Dermatitis (AD) for Indian patients
calcuttanews.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from calcuttanews.net Daily Mail and Mail on Sunday newspapers.

Kabir sardanaSatish udareVibhuti bhattdirectorone advertisingcommunication services ltdIntas pharmaceuticals ltdTofacitinib ointmentAtopic dermatitisTopical calcineurin inhibitorsSenior consultant dermatologistAlok chaturvediActive pharmaceutical ingredientsMedia contact